跳至主要内容
临床试验/TCTR20231114008
TCTR20231114008已完成2 期

The efficacy in adjunctive treatment and safety of Eucerin Complete Repair in the treatment of keratosis pilaris: an open-label, randomized

Beiersdorf Thailand Co.,Ltd0 个研究点目标入组 24 人开始时间: 2023年11月14日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
24

研究概览

简要总结

Eucerin Complete Repair as an adjunctive treatment for keratosis pilaris can significantly improve the treatment outcome.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Healthy individuals aged 18-60 years diagnosed with keratosis pilaris and symmetric keratosis pilaris on both arms of any severity were inclusion criteria of the study.

排除标准

  • Exclusion criteria included a history of vitamin A analog, alpha-hydroxy acid, beta-hydroxy acid, or urea use within the past four months. In addition, the study did not include individuals with a history of esthetic procedures (e.g., chemical peels, laser treatments) on the surface of both arms, other skin conditions affecting both arms, and individuals who were currently pregnant or lactating.

研究者

相似试验